Developer docs
API playgroundTry for free, no card

Search company profiles

CooperVision

Full company profile

uuid000h5wg

Namestring
CooperVision
Legal namestring
CooperVision, Inc.
Company typeenum
Public
Founded yearint
1980
Descriptiontext

CooperVision is one of the world's leading manufacturers of soft contact lenses, operating as a wholly-owned business unit of The Cooper Companies, Inc. (NASDAQ: COO) and serving licensed eye care professionals (optometrists and ophthalmologists) and their patients across more than 130 countries. The company holds an estimated 18-22% share of the global soft contact lens market and delivers prescription lenses for myopia, hyperopia, astigmatism, and presbyopia through five core product families — MyDay, clariti 1 day, Biofinity, Avaira Vitality, and MiSight 1 day — spanning daily disposable, two-week, and monthly replacement schedules, with a specialty eye care division (Blanchard Contact Lenses, Paragon Vision Sciences, and the SynergEyes hybrid lens franchise) addressing complex cases such as keratoconus and irregular corneas.

The company's technology stack is built on silicone hydrogel and hydrogel material platforms, with proprietary optical designs including ActivControl Technology (used in MiSight 1 day and demonstrated to reduce myopia progression in children by approximately 50%, with ~59% reduction over three years of clinical use) and Balanced Progressive Technology in Biofinity multifocal products. CooperVision manufactures at LEED-certified facilities in Alajuela, Costa Rica (Gold, >95% renewable electricity), Juana Diaz, Puerto Rico (Silver), and Scottsville, New York (Silver) — the latter two sites achieving ~30% lower greenhouse gas emissions per manufactured lens since 2021. The portfolio includes the only soft contact lens with myopia control indication approved in Japan, the United States, and China, and the company has introduced ISCC PLUS-certified bio-attributed plastic in packaging as the first contact lens manufacturer to do so.

CooperVision's business model is overwhelmingly a B2B2C hardware sales motion: lenses are sold to eye care professionals who prescribe and fit them, supplemented by a network of authorized U.S. distributors (ABB/CONCISE, Nassau Lens Co, New Era, Newton Group, Wisconsin Vision Associates) and a regional logistics centre in Singapore with CEVA Logistics serving Asia-Pacific. Marketing channels include the coopervision.com website with product education, a find-an-eye-doctor locator, free-trial offers, and patient rebate programs. Pricing is set at the practitioner level and not publicly disclosed; the company has begun layering in alternative revenue plays such as the easyvision private-label portfolio for IDOC alliance members (2026). CooperVision retains no AI/ML or software platform layer; its differentiation rests on materials science, clinical evidence, regulatory approvals, and global manufacturing/distribution reach.

Short descriptiontext

CooperVision is a global soft contact lens manufacturer and wholly-owned business unit of The Cooper Companies (NASDAQ: COO), producing daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity, Avaira, MiSight) for licensed eye care professionals and patients across 130+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersFairport, United States
HQ citystring
Fairport
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices16 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
soft contact lenses, myopia control lenses, silicone hydrogel lenses, daily disposable lenses, multifocal contact lenses
Industry1 code
1Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
CodeHLAHAJAEPrimaryYes
NAICS code1 code
  • Ophthalmic Goods Manufacturing339115
SIC code1 code
  • Ophthalmic Goods3851
Product category
Contact Lenses
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contact Lens Sales
TypeHardware Sales
Description

CooperVision generates revenue through the sale of soft contact lenses across multiple product families including MyDay, Biofinity, clariti, Avaira, and MiSight. Products are sold to eye care professionals and through authorized distributors who then provide to patients.

coopervision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Contact lenses sold through eye care professionals with various product families
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products sold via eye care practitioners with rebate programs available. Individual pricing not publicly disclosed.

coopervision.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Blanchard Vision Corp.
Description

Part of CooperVision Specialty EyeCare, specializing in gas-permeable and specialty contact lenses

coopervision.com
+7 more records
Core offering1 text field

CooperVision manufactures and sells soft contact lenses across multiple product families including MyDay (daily disposable silicone hydrogel), clariti 1 day, Biofinity (monthly replacement), Avaira Vitality (two-week), and MiSight 1 day (myopia control for children). The company addresses all major vision correction needs including myopia, hyperopia, astigmatism, and presbyopia. Products are sold through eye care professionals and authorized distributors in 130+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Approximately 50% reduction in myopia progression in children wearing MiSight 1 day vs single vision daily lenses
+3 more records
Product overview1 text field

CooperVision is one of the world's leading contact lens manufacturers, offering a comprehensive portfolio of soft contact lenses across multiple product families. The company provides daily disposable lenses (MyDay®, clariti® 1 day), two-week lenses (Avaira Vitality™), and monthly replacement lenses (Biofinity®), available in spherical, toric for astigmatism, and multifocal for presbyopia options. CooperVision holds a unique position as the first and only company with FDA-approved myopia control technology through MiSight® 1 day for children. The product portfolio is built on silicone hydrogel material technology, emphasizing breathability, comfort, and oxygen transmission for eye health. Manufacturing facilities in Puerto Rico, Costa Rica, and New York are LEED-certified, with sustainability initiatives including the MADE BETTER™ Promise platform and plastic-neutral packaging through Plastic Bank partnerships. The company also manufactures private label products (easyvision™) and specialty lenses for keratoconus through the SynergEyes acquisition, serving eye care professionals and lens wearers in over 130 countries.

Product and service8 records
1MyDay family
CategorySoft Contact Lenses - Daily Disposable
Description

Premium daily disposable silicone hydrogel contact lenses offering high oxygen transmission and all-day comfort. Includes spherical, toric, and multifocal options for vision correction needs.

2clariti 1 day family
CategorySoft Contact Lenses - Daily Disposable
Description

Daily disposable silicone hydrogel contact lenses offering breathable, comfortable wear with spherical, toric, and multifocal options for vision correction.

3Biofinity family
CategorySoft Contact Lenses - Monthly Replacement
Description

Monthly replacement silicone hydrogel contact lenses offering premium comfort and breathability. Includes extended range (XR) options for higher prescriptions and multiple variants for astigmatism and presbyopia.

4Avaira Vitality family
CategorySoft Contact Lenses - Two-Week Replacement
Description

Two-week silicone hydrogel contact lenses offering high performance and value. Includes spherical and toric options for vision correction including astigmatism.

5MiSight 1 day
CategorySpecialty Contact Lenses - Myopia Control
Description

Daily disposable myopia control contact lens for children aged 8-12 years. Uses ActivControl Technology to slow myopia progression by approximately 50%. First and only FDA-approved soft contact lens for myopia control in the US and Japan.

6easyvision
CategoryPrivate Label Contact Lenses
Description

Private label contact lens portfolio manufactured by CooperVision for IDOC member independent optometrist practices. Based on MyDay and clariti 1 day technologies, offered at lower prices than branded alternatives to help independent optometrists compete against online retailers.

7SynergEyes Hybrid Lenses
CategorySpecialty Contact Lenses - Hybrid
Description

Hybrid contact lens technology acquired through the SynergEyes Inc. acquisition. Designed for keratoconus treatments and specialty fitting applications for patients with irregular cornea conditions.

8CooperVision Specialty EyeCare (Blanchard, Paragon)
CategorySpecialty Contact Lenses - Gas Permeable and Scleral
Description

Specialty eye care division providing specialty contact lenses including gas permeable, orthokeratology, hybrid, and scleral lenses through wholly-owned subsidiaries Blanchard Contact Lenses and Paragon Vision Sciences for complex vision correction needs.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-30
Description

IDOC, a leading U.S. alliance for independent optometrist business owners, launched easyvision, a private label contact lens portfolio manufactured by CooperVision. The brand offers daily disposable lenses based on MyDay and clariti 1 day technologies at prices lower than branded alternatives, exclusively available to IDOC member practices.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-19
Description

CEVA Logistics and CooperVision launched a regional healthcare-focused logistics centre in Singapore's Airport Logistics Park to improve supply chain efficiency for eye care products across Asia Pacific. The facility adds up to 7,000 SKUs to the regional market, reducing fulfillment times and lowering costs. The partnership includes specialized healthcare infrastructure with GDP- and GMP-trained personnel and dedicated warehouse management systems.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2023-01-01
Description

In January 2023, CooperVision acquired SynergEyes Inc. to expand its specialty contact lens portfolio with hybrid lens technology for keratoconus treatments. This acquisition enhanced CooperVision's capabilities in specialty lenses for irregular cornea conditions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

CooperVision's plastic neutrality program partnership with Plastic Bank enables collection and recycling of plastic bottles from coastal communities. Since January 2021, over 659 million plastic bottles have been collected from Indonesia, Egypt, and the Philippines. The partnership funds community development programs including health insurance, nutrition programs, and Wi-Fi access for collectors and their families.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global eyewear and lens giant (Ray-Ban, Oakley, Transitions, Stellest myopia control spectacle lens). Overlaps with CooperVision in vision correction and pediatric myopia management, and dominates the upstream optical retail channel CooperVision depends on.

TypeDirect peer
Description

Major contact lens manufacturer (Biotrue, Ultra, SofLens) with parallel ECP distribution and direct-to-consumer channel. Comparable across soft lens families and specialty lenses.

TypeEmerging player
Description

Emerging player in orthokeratology (ortho-k) and myopia management contact lenses. Competes with CooperVision's Paragon and MiSight portfolios in the pediatric myopia control segment.

TypeDirect peer
Description

Produces contact lenses and intraocular lenses through its Hoya Surgical Optics division. Comparable ophthalmic medical-device manufacturer with global distribution and a specialty IOL franchise adjacent to CooperVision's specialty lens business.

TypeBroad incumbent
Description

Ophthalmic medical device and optics company with intraocular lenses, diagnostics, and surgical microscopy. Not a soft contact lens competitor but a comparable medical-device ophthalmic manufacturer serving ECPs globally.

TypeDirect peer
Description

Specialty contact lens and orthokeratology manufacturer acquired by CooperVision. Operates within CooperVision Specialty EyeCare, providing gas-permeable and ortho-k lenses that compete with Euclid and Bausch + Lomb specialty products.

TypeDirect peer
Description

Global vision-care leader with Dailies, Air Optix, Precision, and PRECISION1 contact lens brands. Directly competes with CooperVision across daily disposable and monthly silicone hydrogel categories, plus broader ophthalmic surgical adjacency.

TypeDirect peer
Description

Hybrid contact lens specialist for keratoconus and irregular corneas, acquired by CooperVision in January 2023. Operates as a specialty-lens brand within the CooperVision Specialty EyeCare division.

TypeDirect peer
Description

Japan-based contact lens manufacturer with strong APAC presence in daily disposable and specialty/orthokeratology lenses. Direct competitor in soft lenses and a natural comparator in the Japan myopia control market.

TypeDirect peer
Description

Largest global contact lens manufacturer through its Acuvue franchise (daily disposables, 2-week, monthly, toric, multifocal). Directly comparable soft-lens portfolio, ECP-channel go-to-market, and broad international regulatory footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CooperVision

Contact Lensescoopervision.com

CooperVision is a global soft contact lens manufacturer and wholly-owned business unit of The Cooper Companies (NASDAQ: COO), producing daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity, Avaira, MiSight) for licensed eye care professionals and patients across 130+ countries.

What CooperVision does

CooperVision is one of the world's leading manufacturers of soft contact lenses, operating as a wholly-owned business unit of The Cooper Companies, Inc. (NASDAQ: COO) and serving licensed eye care professionals (optometrists and ophthalmologists) and their patients across more than 130 countries. The company holds an estimated 18-22% share of the global soft contact lens market and delivers prescription lenses for myopia, hyperopia, astigmatism, and presbyopia through five core product families — MyDay, clariti 1 day, Biofinity, Avaira Vitality, and MiSight 1 day — spanning daily disposable, two-week, and monthly replacement schedules, with a specialty eye care division (Blanchard Contact Lenses, Paragon Vision Sciences, and the SynergEyes hybrid lens franchise) addressing complex cases such as keratoconus and irregular corneas.

The company's technology stack is built on silicone hydrogel and hydrogel material platforms, with proprietary optical designs including ActivControl Technology (used in MiSight 1 day and demonstrated to reduce myopia progression in children by approximately 50%, with ~59% reduction over three years of clinical use) and Balanced Progressive Technology in Biofinity multifocal products. CooperVision manufactures at LEED-certified facilities in Alajuela, Costa Rica (Gold, >95% renewable electricity), Juana Diaz, Puerto Rico (Silver), and Scottsville, New York (Silver) — the latter two sites achieving ~30% lower greenhouse gas emissions per manufactured lens since 2021. The portfolio includes the only soft contact lens with myopia control indication approved in Japan, the United States, and China, and the company has introduced ISCC PLUS-certified bio-attributed plastic in packaging as the first contact lens manufacturer to do so.

CooperVision's business model is overwhelmingly a B2B2C hardware sales motion: lenses are sold to eye care professionals who prescribe and fit them, supplemented by a network of authorized U.S. distributors (ABB/CONCISE, Nassau Lens Co, New Era, Newton Group, Wisconsin Vision Associates) and a regional logistics centre in Singapore with CEVA Logistics serving Asia-Pacific. Marketing channels include the coopervision.com website with product education, a find-an-eye-doctor locator, free-trial offers, and patient rebate programs. Pricing is set at the practitioner level and not publicly disclosed; the company has begun layering in alternative revenue plays such as the easyvision private-label portfolio for IDOC alliance members (2026). CooperVision retains no AI/ML or software platform layer; its differentiation rests on materials science, clinical evidence, regulatory approvals, and global manufacturing/distribution reach.

CooperVision firmographics

Firmographics
Name
CooperVision
Legal name
CooperVision, Inc.
Website
https://coopervision.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
CooperVision is a global soft contact lens manufacturer and wholly-owned business unit of The Cooper Companies (NASDAQ: COO), producing daily, two-week, and monthly silicone hydrogel lenses (MyDay, clariti, Biofinity, Avaira, MiSight) for licensed eye care professionals and patients across 130+ countries.
Ownership category
akta.pro rank

CooperVision industry classification

Industry
Product category
Contact Lenses
NAICS
Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851)
akta.pro primary industry
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

Keywords

  • Soft contact lenses
  • Myopia control lenses
  • Silicone hydrogel lenses
  • Daily disposable lenses
  • Multifocal contact lenses

Where CooperVision is headquartered

Location

Headquarters

HQ city
Fairport
HQ country
United States
HQ region
North America

Offices16 records

Markets served

CooperVision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contact Lens Sales: CooperVision generates revenue through the sale of soft contact lenses across multiple product families including MyDay, Biofinity, clariti, Avaira, and MiSight. Products are sold to eye care professionals and through authorized distributors who then provide to patients.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goContact lenses sold through eye care professionals with various product families

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

CooperVision product offering

Product offering

Core offering

CooperVision manufactures and sells soft contact lenses across multiple product families including MyDay (daily disposable silicone hydrogel), clariti 1 day, Biofinity (monthly replacement), Avaira Vitality (two-week), and MiSight 1 day (myopia control for children). The company addresses all major vision correction needs including myopia, hyperopia, astigmatism, and presbyopia. Products are sold through eye care professionals and authorized distributors in 130+ countries.

Product overview

CooperVision is one of the world's leading contact lens manufacturers, offering a comprehensive portfolio of soft contact lenses across multiple product families. The company provides daily disposable lenses (MyDay®, clariti® 1 day), two-week lenses (Avaira Vitality™), and monthly replacement lenses (Biofinity®), available in spherical, toric for astigmatism, and multifocal for presbyopia options. CooperVision holds a unique position as the first and only company with FDA-approved myopia control technology through MiSight® 1 day for children. The product portfolio is built on silicone hydrogel material technology, emphasizing breathability, comfort, and oxygen transmission for eye health. Manufacturing facilities in Puerto Rico, Costa Rica, and New York are LEED-certified, with sustainability initiatives including the MADE BETTER™ Promise platform and plastic-neutral packaging through Plastic Bank partnerships. The company also manufactures private label products (easyvision™) and specialty lenses for keratoconus through the SynergEyes acquisition, serving eye care professionals and lens wearers in over 130 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Blanchard Vision Corp. Part of CooperVision Specialty EyeCare, specializing in gas-permeable and specialty contact lenses
  • Paragon Vision Sciences
  • MyDay
  • clariti 1 day
  • Biofinity
  • Avaira Vitality
  • MiSight 1 day
  • MADE BETTER Promise

Products and services

  • MyDay family Premium daily disposable silicone hydrogel contact lenses offering high oxygen transmission and all-day comfort. Includes spherical, toric, and multifocal options for vision correction needs.
  • clariti 1 day family Daily disposable silicone hydrogel contact lenses offering breathable, comfortable wear with spherical, toric, and multifocal options for vision correction.
  • Biofinity family Monthly replacement silicone hydrogel contact lenses offering premium comfort and breathability. Includes extended range (XR) options for higher prescriptions and multiple variants for astigmatism and presbyopia.
  • Avaira Vitality family Two-week silicone hydrogel contact lenses offering high performance and value. Includes spherical and toric options for vision correction including astigmatism.
  • MiSight 1 day Daily disposable myopia control contact lens for children aged 8-12 years. Uses ActivControl Technology to slow myopia progression by approximately 50%. First and only FDA-approved soft contact lens for myopia control in the US and Japan.
  • easyvision Private label contact lens portfolio manufactured by CooperVision for IDOC member independent optometrist practices. Based on MyDay and clariti 1 day technologies, offered at lower prices than branded alternatives to help independent optometrists compete against online retailers.
  • SynergEyes Hybrid Lenses Hybrid contact lens technology acquired through the SynergEyes Inc. acquisition. Designed for keratoconus treatments and specialty fitting applications for patients with irregular cornea conditions.
  • CooperVision Specialty EyeCare (Blanchard, Paragon) Specialty eye care division providing specialty contact lenses including gas permeable, orthokeratology, hybrid, and scleral lenses through wholly-owned subsidiaries Blanchard Contact Lenses and Paragon Vision Sciences for complex vision correction needs.

Quantifiable outcome

  • Approximately 50% reduction in myopia progression in children wearing MiSight 1 day vs single vision daily lenses
  • +3 more outcomes

Companies that use CooperVision

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

CooperVision technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

CooperVision partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered strategic and core.

  • IDOCstrategicChannel Partner/ Reseller/ Distributor · 30 March 2026IDOC, a leading U.S. alliance for independent optometrist business owners, launched easyvision, a private label contact lens portfolio manufactured by CooperVision. The brand offers daily disposable lenses based on MyDay and clariti 1 day technologies at prices lower than branded alternatives, exclusively available to IDOC member practices.
  • CEVA LogisticscoreChannel Partner/ Reseller/ Distributor · 19 January 2026CEVA Logistics and CooperVision launched a regional healthcare-focused logistics centre in Singapore's Airport Logistics Park to improve supply chain efficiency for eye care products across Asia Pacific. The facility adds up to 7,000 SKUs to the regional market, reducing fulfillment times and lowering costs. The partnership includes specialized healthcare infrastructure with GDP- and GMP-trained personnel and dedicated warehouse management systems.
  • SynergEyes Inc.strategicTechnology or Integration · 1 January 2023In January 2023, CooperVision acquired SynergEyes Inc. to expand its specialty contact lens portfolio with hybrid lens technology for keratoconus treatments. This acquisition enhanced CooperVision's capabilities in specialty lenses for irregular cornea conditions.
  • Plastic BankcoreStrategic or Co-development Partner · 1 January 2021CooperVision's plastic neutrality program partnership with Plastic Bank enables collection and recycling of plastic bottles from coastal communities. Since January 2021, over 659 million plastic bottles have been collected from Indonesia, Egypt, and the Philippines. The partnership funds community development programs including health insurance, nutrition programs, and Wi-Fi access for collectors and their families.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

CooperVision competitors and assessment

Company assessment

Broad incumbents

  • EssilorLuxottica: Global eyewear and lens giant (Ray-Ban, Oakley, Transitions, Stellest myopia control spectacle lens). Overlaps with CooperVision in vision correction and pediatric myopia management, and dominates the upstream optical retail channel CooperVision depends on.
  • Carl Zeiss Meditec: Ophthalmic medical device and optics company with intraocular lenses, diagnostics, and surgical microscopy. Not a soft contact lens competitor but a comparable medical-device ophthalmic manufacturer serving ECPs globally.

Direct peers

  • Bausch + Lomb: Major contact lens manufacturer (Biotrue, Ultra, SofLens) with parallel ECP distribution and direct-to-consumer channel. Comparable across soft lens families and specialty lenses.
  • Hoya Corporation: Produces contact lenses and intraocular lenses through its Hoya Surgical Optics division. Comparable ophthalmic medical-device manufacturer with global distribution and a specialty IOL franchise adjacent to CooperVision's specialty lens business.
  • Paragon Vision Sciences (now part of CooperVision): Specialty contact lens and orthokeratology manufacturer acquired by CooperVision. Operates within CooperVision Specialty EyeCare, providing gas-permeable and ortho-k lenses that compete with Euclid and Bausch + Lomb specialty products.
  • Alcon: Global vision-care leader with Dailies, Air Optix, Precision, and PRECISION1 contact lens brands. Directly competes with CooperVision across daily disposable and monthly silicone hydrogel categories, plus broader ophthalmic surgical adjacency.
  • SynergEyes (now part of CooperVision): Hybrid contact lens specialist for keratoconus and irregular corneas, acquired by CooperVision in January 2023. Operates as a specialty-lens brand within the CooperVision Specialty EyeCare division.
  • Menicon: Japan-based contact lens manufacturer with strong APAC presence in daily disposable and specialty/orthokeratology lenses. Direct competitor in soft lenses and a natural comparator in the Japan myopia control market.
  • Johnson & Johnson Vision: Largest global contact lens manufacturer through its Acuvue franchise (daily disposables, 2-week, monthly, toric, multifocal). Directly comparable soft-lens portfolio, ECP-channel go-to-market, and broad international regulatory footprint.

Emerging players

  • Euclid Systems: Emerging player in orthokeratology (ortho-k) and myopia management contact lenses. Competes with CooperVision's Paragon and MiSight portfolios in the pediatric myopia control segment.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CooperVision social profiles

Digital presence

CooperVision compliance and trust

Trust signal

Compliance6 records

CooperVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CooperVision leadership team

Management profile

Number of profiles

Profiles7 records

CooperVision subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

CooperVision funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CooperVision M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CooperVision

What does CooperVision do?

CooperVision manufactures and sells soft contact lenses across multiple product families including MyDay (daily disposable silicone hydrogel), clariti 1 day, Biofinity (monthly replacement), Avaira Vitality (two-week), and MiSight 1 day (myopia control for children). The company addresses all major vision correction needs including myopia, hyperopia, astigmatism, and presbyopia. Products are sold through eye care professionals and authorized distributors in 130+ countries.

Is CooperVision a public or private company?

CooperVision is a public company. It is classified as public and is currently operating.

When was CooperVision founded?

CooperVision was founded in 1980. It employs 1,001 to 5,000 people.

Where is CooperVision based?

CooperVision is headquartered in Fairport, United States, in the North America region.

How does CooperVision make money?

One revenue line is on record: contact Lens Sales.

Who are CooperVision's main competitors?

Broad incumbents on record are EssilorLuxottica and Carl Zeiss Meditec. Direct peers are Bausch + Lomb, Hoya Corporation, Paragon Vision Sciences (now part of CooperVision), Alcon, SynergEyes (now part of CooperVision), Menicon and Johnson & Johnson Vision. Euclid Systems is listed as an emerging player.

Does CooperVision have an API?

No public API is recorded for CooperVision.

What industry is CooperVision in?

CooperVision's product category is Contact Lenses. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNew CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging SolutionCooperVision's 2026 consumer insights report finds U.S. adults rank multifocal contact lenses as a leading anti-aging solution, with two-thirds wanting to maintain a younger appearance. Nearly half are unfamiliar with the lenses, and three-quarters of familiar respondents would consider wearing them. The report urges eye care professionals to discuss presbyopia earlier.Financial PostSeneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision careSeneca Polytechnic and CooperVision Canada opened the CooperVision Contact Lens Centre of Excellence at Seneca's Newnham Campus. The facility provides hands-on training in contact lens fitting, assessment, dispensing, and patient education, strengthening industry-education connections. It will also host educational events and collaborative programming.RbjRochester area key to CooperVision’s contact lens growth strategyCooperVision's Rochester-area operations, including its West Henrietta facility, are central to its strategy to gain top U.S. contact lens market share. The company completed a $38 million expansion of the facility in 2023, part of a $62 million investment, and plans three U.S. product launches over the next 12 to 24 months.PresseportalLehrkräfte-Befragung zeigt: Kontaktlinsen für Kinder noch immer die AusnahmeA CooperVision survey of 263 German elementary schools found 98% of children needing vision correction wear glasses, with contact lenses rarely used. Teachers cite safety concerns in sports and lack of structured eye-health procedures, while 67% want more information on myopia screening.YahooCOO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVisionThe Cooper Companies COO announced the opening of The Vision Centre, a global innovation hub in Southampton for CooperVision, and unveiled six product advancements across myopia control, silicone hydrogel, toric, and multifocal lenses. The company expects these investments to accelerate product launches and support sustainable growth, with the stock gaining 1.4% on the news.BioSpaceCooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre OpeningCooperCompanies opened The Vision Centre, a global innovation hub in Southampton, England, and announced six accelerated product launches for CooperVision. The pipeline includes a complete family of 1-day myopia control contact lenses and new silicone hydrogel technologies. The company expects to provide additional updates over the coming quarters.MarketScreenerCoopervision Open the Vision Centre in Southampton, EnglandCooperVision opened its new global innovation hub, The Vision Centre, in Southampton, England. The facility integrates research, clinical expertise, pilot manufacturing, and advanced technologies to accelerate development and commercialization of eye care solutions. It will serve as a global center for research, clinical studies, and new product introduction.FinancialContent Business PageCooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre OpeningCooperCompanies opened its new global innovation hub, The Vision Centre, in Southampton, England, and announced six accelerated product launches for CooperVision. The launches include a complete family of 1-day myopia control contact lenses and novel silicone hydrogel technologies. The company plans to provide additional updates over the coming quarters.Stock TitanCooperVision Opens Vision Centre, Plans 6 Lens AdvancesCooperVision opened its new global Vision Centre in Southampton, England, and announced six major contact lens product advancements. The innovations include a complete family of 1-day myopia-control lenses and a novel premium silicone hydrogel technology. The 9,940-square-meter facility will house about 350 employees.PR NewswireCooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline AdvancementsCooperVision opened its new global Vision Centre in Southampton, England, and announced six major contact lens product advancements. The facility spans 9,940 square meters and will house about 350 employees, aiming to accelerate innovation from research to market.